Jan B. Egan
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Multiple Myeloma Research and Treatments 8
-
- Cancer Genomics and Diagnostics 6
- Co-authors
- A. Keith Stewart (8 shared papers)Esteban Braggio (10 shared papers)Rafaël Fonseca (8 shared papers)Peter Leif Bergsagel (4 shared papers)John David Carpten (6 shared papers)Jonathan J. Keats (2 shared papers)Scott Van Wier (4 shared papers)Marta Chesi (3 shared papers)
- Journals
- Blood (6 papers)PLoS ONE (3 papers)Oncotarget (2 papers)The Journal of Steroid Biochemistry and Molecular Biology (2 papers)Scientific Reports (2 papers)
- Partner nations
- United StatesBrazilGermany
In The Last Decade
Jan B. Egan
41 papers receiving 2.5k citations
Jan B. Egan's Hit Papers
Peers
Comparison fields: 5 of 87
- Hematology 942
- Cancer Research 285
- Pathology and Forensic Medicine 285
- Neurology 144
- Oncology 158
Countries citing papers authored by Jan B. Egan
This map shows the geographic impact of Jan B. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan B. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan B. Egan more than expected).
Fields of papers citing papers by Jan B. Egan
This network shows the impact of papers produced by Jan B. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan B. Egan. The network helps show where Jan B. Egan may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan B. Egan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clonal competition with alternating dominance in multiple myeloma Hit paper breakdown → | 2012 | 550 |
| 2 | 2012 | 343 | |
| 3 | Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma Hit paper breakdown → | 2014 | 301 |
| 4 | 2015 | 185 | |
| 5 | 2010 | 151 | |
| 6 | 2013 | 143 | |
| 7 | 2009 | 64 | |
| 8 | 2012 | 64 | |
| 9 | 2017 | 57 | |
| 10 | 2013 | 54 | |
| 11 | 2013 | 48 | |
| 12 | 2015 | 46 | |
| 13 | 2010 | 44 | |
| 14 | 2014 | 43 | |
| 15 | 2023 | 43 | |
| 16 | 2017 | 41 | |
| 17 | 2021 | 40 | |
| 18 | 2021 | 39 | |
| 19 | 2010 | 35 | |
| 20 | 2016 | 31 |
About Jan B. Egan
Jan B. Egan is a scholar working on Hematology, Cancer Research, Genetics, Pathology and Forensic Medicine and Surgery, having authored 44 papers that have together received 2.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Cancer Genomics and Diagnostics (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Vitamin D Research Studies (4 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), BRCA gene mutations in cancer (3 papers), Virus-based gene therapy research (2 papers) and Genomics and Rare Diseases (2 papers). The work is most often cited by research in Hematology (942 citations), Cancer Research (285 citations), Pathology and Forensic Medicine (285 citations), Neurology (144 citations) and Oncology (158 citations). Jan B. Egan has collaborated with scholars based in United States, Brazil and Germany. Frequent co-authors include A. Keith Stewart, Esteban Braggio, Rafaël Fonseca, Peter Leif Bergsagel, John David Carpten, Jonathan J. Keats, Scott Van Wier, Marta Chesi, Victoria Marie Garbitt and Angela S. Baker. Their work appears in journals such as Blood, PLoS ONE, Oncotarget, The Journal of Steroid Biochemistry and Molecular Biology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.